120 results
424B3
ELVN
Enliven Therapeutics Inc
30 Apr 24
Prospectus supplement
4:16pm
, in some cases, for the purpose of allocating risk among the parties thereto, and should not be deemed to be a representation, warranty or covenant to you … to the selling stockholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling stockholders may
PRE 14A
ELVN
Enliven Therapeutics Inc
15 Apr 24
Preliminary proxy
4:05pm
disease, from November 2015 to August 2022, BCTG Acquisition Corp., a special purpose acquisition company, from September 2020 to August 2021, and Yumanity … independent auditor for the purpose of auditing our financial statements, books, records, accounts and internal control over financial reporting
8-K
EX-10.1
191iwejs wkxp11y1
19 Mar 24
Enliven Therapeutics Announces $90 Million Private Placement Financing and Provides Pipeline Updates
8:46am
8-K
EX-4.1
r2i4dg2ansxnm7hz20wm
19 Mar 24
Enliven Therapeutics Announces $90 Million Private Placement Financing and Provides Pipeline Updates
8:46am
S-8
8yapvs0t
14 Mar 24
Registration of securities for employees
5:15pm
S-8
v6ntimdu2b9
14 Mar 24
Registration of securities for employees
5:15pm